A long-term follow-up study on otoacoustic emissions testing in paediatric patients with severe malaria in Gabon.
Children
Hearing loss
Otoacoustic emissions
Severe malaria
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
24 Jun 2019
24 Jun 2019
Historique:
received:
05
08
2018
accepted:
17
06
2019
entrez:
26
6
2019
pubmed:
27
6
2019
medline:
8
10
2019
Statut:
epublish
Résumé
In a previous study, severe and cerebral malaria have been connected with acute cochlear malfunction in children, demonstrated by a decrease of transitory evoked otoacoustic emissions (TEOAEs) reproducibility. This study aims to determine whether cochlear malfunction persists for 4 years after recovery from severe malaria in a subset of the previous study's collective. Follow-up TEOAEs were performed on site (CERMEL, Hôpital Albert Schweitzer, Lambaréné, Gabon) or at the participants' homes; 33 out of 90 participants included in the initial investigation by Schmutzhard et al. could be retrieved and were re-examined, 31/33 could be included. Of the 57 missing participants, 51 could not be contacted, 1 had moved away, 4 refused to cooperate, and 1 had died. As in the initial investigation, participants of this prospective follow-up study were subjected to TEOAE examination on both ears separately. A wave correlation rate of > 60% on both ears was considered a "pass"; if one ear failed to pass, the examination was considered a "fail". The results were compared to the primary control group. Additionally, a questionnaire has been applied focusing on subsequent malaria infections between the primary inclusion and follow-up and subjective impairment of hearing and/or understanding. The cohort's mean age was 9 years, 14 children were female, 18 male. 31 had been originally admitted with severe, one with cerebral malaria. 83.8% of participants (n = 26) presented with a TEOAE correlation rate of > 60% on both ears (the cut-off for good cochlear function); in the control group, 92.2% (n = 83) had passed TEOAE examination on both ears. Recurrent severe malaria was associated with a worse TEOAE correlation rate. Age at infection and gender had no influence on the outcome. Cochlear malfunction seems to be persistent after 4 years in more than 16% of children hospitalized for malaria. In a healthy control group, this proportion was 7.8%. Yet, the severity of the initial TEOAE-decrease did not predict a worse outcome.
Sections du résumé
BACKGROUND
BACKGROUND
In a previous study, severe and cerebral malaria have been connected with acute cochlear malfunction in children, demonstrated by a decrease of transitory evoked otoacoustic emissions (TEOAEs) reproducibility. This study aims to determine whether cochlear malfunction persists for 4 years after recovery from severe malaria in a subset of the previous study's collective. Follow-up TEOAEs were performed on site (CERMEL, Hôpital Albert Schweitzer, Lambaréné, Gabon) or at the participants' homes; 33 out of 90 participants included in the initial investigation by Schmutzhard et al. could be retrieved and were re-examined, 31/33 could be included. Of the 57 missing participants, 51 could not be contacted, 1 had moved away, 4 refused to cooperate, and 1 had died.
METHODS
METHODS
As in the initial investigation, participants of this prospective follow-up study were subjected to TEOAE examination on both ears separately. A wave correlation rate of > 60% on both ears was considered a "pass"; if one ear failed to pass, the examination was considered a "fail". The results were compared to the primary control group. Additionally, a questionnaire has been applied focusing on subsequent malaria infections between the primary inclusion and follow-up and subjective impairment of hearing and/or understanding.
RESULTS
RESULTS
The cohort's mean age was 9 years, 14 children were female, 18 male. 31 had been originally admitted with severe, one with cerebral malaria. 83.8% of participants (n = 26) presented with a TEOAE correlation rate of > 60% on both ears (the cut-off for good cochlear function); in the control group, 92.2% (n = 83) had passed TEOAE examination on both ears. Recurrent severe malaria was associated with a worse TEOAE correlation rate. Age at infection and gender had no influence on the outcome.
CONCLUSIONS
CONCLUSIONS
Cochlear malfunction seems to be persistent after 4 years in more than 16% of children hospitalized for malaria. In a healthy control group, this proportion was 7.8%. Yet, the severity of the initial TEOAE-decrease did not predict a worse outcome.
Identifiants
pubmed: 31234890
doi: 10.1186/s12936-019-2840-9
pii: 10.1186/s12936-019-2840-9
pmc: PMC6591898
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
212Références
Am J Otol. 2000 Jan;21(1):88-91
pubmed: 10651440
Clin Ter. 1999 Sep-Oct;150(5):379-82
pubmed: 10687269
Laryngoscope. 2002 Mar;112(3):513-9
pubmed: 12148864
Br Med Bull. 2002;63:223-41
pubmed: 12324396
Trop Med Int Health. 2005 Jan;10(1):3-10
pubmed: 15655008
J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):476-81
pubmed: 15774431
Lancet Neurol. 2005 Dec;4(12):827-40
pubmed: 16297841
Pediatrics. 2006 Feb;117(2):e298-319
pubmed: 16452337
Exp Neurol. 2006 Jul;200(1):216-26
pubmed: 16624296
Neuropathol Appl Neurobiol. 2007 Oct;33(5):560-71
pubmed: 17442059
Laryngoscope. 1991 Dec;101(12 Pt 1):1264-72
pubmed: 1766294
Travel Med Infect Dis. 2007 Nov;5(6):385-8
pubmed: 17983978
Malar J. 2008 Sep 16;7:179
pubmed: 18796142
Lancet. 1990 Oct 27;336(8722):1039-43
pubmed: 1977027
BMC Res Notes. 2010 Apr 16;3:104
pubmed: 20398391
Pediatrics. 2010 Jun;125(6):e1348-55
pubmed: 20457680
Malar J. 2010 Jun 11;9:159
pubmed: 20540722
Pediatrics. 2010 Aug;126 Suppl 1:S3-6
pubmed: 20679318
Ann Trop Paediatr. 2011;31(1):1-10
pubmed: 21262104
Malar J. 2012 Feb 01;11:30
pubmed: 22297132
Iran J Pediatr. 2013 Apr;23(2):199-204
pubmed: 23724183
Int J Pediatr Otorhinolaryngol. 2014 May;78(5):711-7
pubmed: 24613088
Front Hum Neurosci. 2014 Mar 25;8:164
pubmed: 24723873
Am J Trop Med Hyg. 2014 Jul;91(1):62-73
pubmed: 24865683
HNO. 2014 Oct;62(10):702-17
pubmed: 25270968
Am J Audiol. 2015 Jun;24(2):250-67
pubmed: 25760393
Int J Pediatr Otorhinolaryngol. 2015 Jun;79(6):829-33
pubmed: 25887133
BMC Med. 2015 May 28;13:125
pubmed: 26021376
Int J Pediatr Otorhinolaryngol. 2015 Sep;79(9):1455-61
pubmed: 26166450
Hippokratia. 2016 Apr-Jun;20(2):104-109
pubmed: 28416905
Int J Pediatr Otorhinolaryngol. 2017 Oct;101:65-69
pubmed: 28964312
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017 Dec 18;16:Doc09
pubmed: 29279727
Pediatrics. 1984 Aug;74(2):206-16
pubmed: 6462820
J Acoust Soc Am. 1978 Nov;64(5):1386-91
pubmed: 744838
Arch Dis Child. 1995 Apr;72(4):294-7
pubmed: 7763058
Drug Saf. 1995 Jun;12(6):370-83
pubmed: 8527012
Acta Otolaryngol. 1996 Sep;116(5):672-9
pubmed: 8908242